Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

January 03, 2024 11:04 (London Time)

Immix Biopharma

Youtube Subscribe

...

Sector: Biotechnology
Ticker: IMMX
Sentiment: 0.4019
MarketCap: 120,395,377.0
High: 6.88 Low: 5.83

Open: 6.82 Close: 6.06 Change: -0.76

The best way to get information about Immix Biopharma Company Inc Stock: Use an AI.

This document will help you to evaluate Immix Biopharma without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Immix Biopharma are: Immix, Biopharma, NASDAQIMMX, trading, defense, world, immix, …

Concept Map

...

Semantic Network

...

Stock Summary

Immix Biopharma, Inc. engages in developing tissue-specific therapeutics in oncology and inflammation. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft.

Today's Summary

Immix Biopharma (NASDAQ:IMMX) trading down 12.4% - defense world. immix biopharma. Director Jason Hsu bought 25,000 shares of the companys stock in a transaction dated Friday, December 8th. The firm has a market cap of $120.41 million, a P/E ratio of -6.59. Immix Biopharma, Inc. Completes 3rd NXC-201 Engineering Batch at its U.S. clinical trial. ImmixBio is a clinical-stage biopharmaceutical company pioneering personalized therapies.

Today's News

Immix Biopharma (NASDAQ:IMMX) trading down 12.4% - defense world. immix biopharma. Director Jason Hsu bought 25,000 shares of the companys stock in a transaction dated Friday, December 8th. The firm has a market cap of $120.41 million, a P/E ratio of -6.59. Immix Biopharma, Inc. Completes 3rd NXC-201 Engineering Batch at its U.S. clinical trial. ImmixBio is a clinical-stage biopharmaceutical company pioneering personalized therapies.

Stock Profile

"Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles, California."

Keywords

Are looking for the most relevant information about Immix Biopharma? Investor spend a lot of time searching for information to make investment decisions in Immix Biopharma. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Immix Biopharma are: Immix, Biopharma, NASDAQIMMX, trading, defense, world, immix, and the most common words in the summary are: therapeutic, pharmaceutical, inc, biopharma, pharma, bioscience, science, . One of the sentences in the summary was: Completes 3rd NXC-201 Engineering Batch at its U.S. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #pharmaceutical #inc #biopharma #pharma #bioscience #science.

Read more →

Related Results

...
February 13, 2024 6:16 (London Time)

Immix Biopharma

Immix Biopharma Inc (IMMX) stock is lower by -2.01% while the S&P 500 is up 0.31% as of 10:58 AM on Friday, Feb 9. Immix biopharma awarded european …
Sector: Biotechnology
Ticker: IMMX
Sentiment: 0.3612
MarketCap: 78,392,118.0
High: 3.3 Low: 2.98

Open: 3.22 Close: 3.06 Change: -0.16

Read more →
...
May 19, 2023 11:31 (London Time)

Immix Biopharma

Immix Biopharma Inc (IMMX) Stock Price Today, News, Quotes, Quoting, FAQs and Fundamentals. Immix biopharma inc (immx) stock price today, news, quot…
Sector: Biotechnology
Ticker: IMMX
Sentiment: 0.0
MarketCap: 24,689,414.0
High: 1.97 Low: 1.77

Open: 1.77 Close: 1.91 Change: 0.14

Read more →
...
January 03, 2024 11:04 (London Time)

Immix Biopharma

Immix Biopharma (NASDAQ:IMMX) trading down 12.4% - defense world. immix biopharma. Director Jason Hsu bought 25,000 shares of the companys stock in …
Sector: Biotechnology
Ticker: IMMX
Sentiment: 0.4019
MarketCap: 120,395,377.0
High: 6.88 Low: 5.83

Open: 6.82 Close: 6.06 Change: -0.76

Read more →